世界の眼科用治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04058)
◆英語タイトル:Global Ophthalmic Therapeutic Drugs Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04058
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは眼科用治療薬の世界市場について調査・分析した資料です。種類別(抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他)の市場規模、用途別(病院薬局、オンライン薬局、独立薬局、ドラッグストア)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別眼科用治療薬の競争状況、市場シェア
・世界の眼科用治療薬市場:種類別市場規模 2015年-2020年(抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他)
・世界の眼科用治療薬市場:種類別市場規模予測 2021年-2026年(抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他)
・世界の眼科用治療薬市場:用途別市場規模 2015年-2020年(病院薬局、オンライン薬局、独立薬局、ドラッグストア)
・世界の眼科用治療薬市場:用途別市場規模予測 2021年-2026年(病院薬局、オンライン薬局、独立薬局、ドラッグストア)
・北米の眼科用治療薬市場分析:米国、カナダ
・ヨーロッパの眼科用治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの眼科用治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の眼科用治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの眼科用治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Bausch Health、Genentech、Regeneron Pharmaceuticals、Takeda、Santen Pharmaceutical
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market
The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026.

Global Ophthalmic Therapeutic Drugs Scope and Market Size
Ophthalmic Therapeutic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Bausch Health
Genentech
Regeneron Pharmaceuticals
Takeda
Santen Pharmaceutical

Market segment by Type, the product can be split into
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ophthalmic Therapeutic Drugs Revenue
1.4 Market by Type
1.4.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-inflammatory Drugs
1.4.3 Anti-infective Drugs
1.4.4 Anti-glaucoma Drugs
1.4.5 Anti-allergy Drugs
1.4.6 Anti-VEGF Agents
1.4.7 Others
1.5 Market by Application
1.5.1 Global Ophthalmic Therapeutic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Independent Pharmacies & Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Ophthalmic Therapeutic Drugs Market Perspective (2015-2026)
2.2 Global Ophthalmic Therapeutic Drugs Growth Trends by Regions
2.2.1 Ophthalmic Therapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ophthalmic Therapeutic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Ophthalmic Therapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ophthalmic Therapeutic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Ophthalmic Therapeutic Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Therapeutic Drugs Players by Market Size
3.1.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue (2015-2020)
3.1.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio
3.2.1 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutic Drugs Revenue in 2019
3.3 Ophthalmic Therapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Ophthalmic Therapeutic Drugs Product Solution and Service
3.5 Date of Enter into Ophthalmic Therapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Ophthalmic Therapeutic Drugs Market Size (2015-2020)
6.2 Ophthalmic Therapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Ophthalmic Therapeutic Drugs Market Size (2015-2020)
7.2 Ophthalmic Therapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

8 China
8.1 China Ophthalmic Therapeutic Drugs Market Size (2015-2020)
8.2 Ophthalmic Therapeutic Drugs Key Players in China (2019-2020)
8.3 China Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
8.4 China Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Ophthalmic Therapeutic Drugs Market Size (2015-2020)
9.2 Ophthalmic Therapeutic Drugs Key Players in Japan (2019-2020)
9.3 Japan Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
9.4 Japan Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Ophthalmic Therapeutic Drugs Market Size (2015-2020)
10.2 Ophthalmic Therapeutic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

11 India
11.1 India Ophthalmic Therapeutic Drugs Market Size (2015-2020)
11.2 Ophthalmic Therapeutic Drugs Key Players in India (2019-2020)
11.3 India Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
11.4 India Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Ophthalmic Therapeutic Drugs Market Size (2015-2020)
12.2 Ophthalmic Therapeutic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction
13.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction
13.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction
13.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 ALLERGAN
13.4.1 ALLERGAN Company Details
13.4.2 ALLERGAN Business Overview
13.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction
13.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.4.5 ALLERGAN Recent Development
13.5 Aerie Pharmaceuticals
13.5.1 Aerie Pharmaceuticals Company Details
13.5.2 Aerie Pharmaceuticals Business Overview
13.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
13.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.5.5 Aerie Pharmaceuticals Recent Development
13.6 Bausch Health
13.6.1 Bausch Health Company Details
13.6.2 Bausch Health Business Overview
13.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction
13.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.6.5 Bausch Health Recent Development
13.7 Genentech
13.7.1 Genentech Company Details
13.7.2 Genentech Business Overview
13.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction
13.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.7.5 Genentech Recent Development
13.8 Regeneron Pharmaceuticals
13.8.1 Regeneron Pharmaceuticals Company Details
13.8.2 Regeneron Pharmaceuticals Business Overview
13.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
13.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.8.5 Regeneron Pharmaceuticals Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction
13.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.9.5 Takeda Recent Development
13.10 Santen Pharmaceutical
13.10.1 Santen Pharmaceutical Company Details
13.10.2 Santen Pharmaceutical Business Overview
13.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction
13.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.10.5 Santen Pharmaceutical Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Bausch Health、Genentech、Regeneron Pharmaceuticals、Takeda、Santen Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の眼科用治療薬市場2026:インサイト・予測(Global Ophthalmic Therapeutic Drugs Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。